Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: May 14, 2018
Reporting Period: Quarter ended March 31, 2018
Status: Emerging Growth Company
Key Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release regarding the quarter ended March 31, 2018. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained in the unaudited condensed consolidated financial statements and press release furnished as Exhibit 99.1, which are incorporated by reference but not reproduced in this document.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text provided. It directs readers to the press release (Exhibit 99.1) for operational results and financial condition updates.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on May 14, 2018, announcing earnings and making other disclosures.
Legal Disclaimer: The information in Item 2.02, including the press release, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 14, 2018) for specific Q1 2018 revenue and earnings figures.
- Examine the unaudited condensed consolidated financial statements included in Exhibit 99.1 for cash flow and liquidity data.
- Verify the Company's status as an Emerging Growth Company and its election regarding the extended transition period for new accounting standards.
- Confirm that the financial data in the press release is not considered "filed" under Section 18 of the Exchange Act unless specifically referenced in other filings.